Stanley C Erck

CIK 1342826 · President and CEO · last filed 2025-08-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.19M

Companies

4

Total Filings

68

Lifetime Open-Market Net

-$50.97M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MXCT Director 398,328 $1.12 $446.1K -$410.6K 9 2025-08-13
NVAX President and CEO 36,492 $8.88 $324.0K -$49.70M 42 2022-12-16
BCRX Director 48,333 $8.70 $420.5K $48.9K 12 2018-11-30
INTERCELL USA, INC. (IOMI) Delisted President & CEO 33,201 -$906.2K 4 2008-07-31

Recent Filings · Page 4 of 7

68 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-05-15 NVAX Buy (P) +100,000 $164.6K EDGAR
2017-12-19 NVAX Grant (A) $0 EDGAR
2017-11-13 NVAX Buy (P) +100,000 $113.0K EDGAR
2017-05-25 BCRX Grant (A) $0 EDGAR
2017-05-11 NVAX Buy (P) +50,000 $42.0K EDGAR
2016-11-16 NVAX Grant (A) $0 EDGAR
2016-05-25 BCRX Grant (A) $0 EDGAR
2016-04-01 NVAX Mixed −24,778 -$1.69M EDGAR
2016-03-17 NVAX Grant (A) $0 EDGAR
2016-02-01 NVAX Buy (P) +2,072 $9.1K EDGAR
Showing 3140 of 68
Page 4 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.